Product logins

Find logins to all Clarivate products below.


Blog: Pharma

Here you will find relevant articles and insight into all Clarivate related products and news.

Navigating the choppy waters of 2027 health exchange enrollment Navigating the choppy waters of 2027 health exchange enrollment
Blog October 30, 2026
Navigating the choppy waters of 2027 health exchange enrollment
Biopharma Biotech HMO
Most Favored Nation drug pricing: How it works Most Favored Nation drug pricing: How it works
Blog October 29, 2026
Most Favored Nation drug pricing: How it works
Biopharma Biotech Commercialization
Multi-product portfolios: addressing complexity through smarter value communication Multi-product portfolios: addressing complexity through smarter value communication
Blog October 9, 2026
Multi-product portfolios: addressing complexity through smarter value communication
Biopharma Commercialization HMO
From promise to payment: pricing and reimbursement for combination oncology regimens From promise to payment: pricing and reimbursement for combination oncology regimens
Blog October 9, 2026
From promise to payment: pricing and reimbursement for combination oncology regimens
Biopharma Biotech Bispecific antibodies
Faulty pharmaceutical forecasting can skew launch planning and sour investors Faulty pharmaceutical forecasting can skew launch planning and sour investors
Blog September 25, 2026
Faulty pharmaceutical forecasting can skew launch planning and sour investors
AI Biopharma Biotech
Biopharma’s pricing pains: Trump’s MFN policy scrambles launch plans Biopharma’s pricing pains: Trump’s MFN policy scrambles launch plans
Blog September 22, 2026
Biopharma’s pricing pains: Trump’s MFN policy scrambles launch plans
Biopharma Biotech Commercialization
How three clinical trial registries tracked a $718M obesity drug (and why one wasn't enough) How three clinical trial registries tracked a $718M obesity drug (and why one wasn't enough)
Blog August 25, 2026
How three clinical trial registries tracked a $718M obesity drug (and why one wasn't enough)
APAC Asia-Pacific Biopharma
7 weight loss companies to watch: innovators in GLP-1s and beyond 7 weight loss companies to watch: innovators in GLP-1s and beyond
Blog August 5, 2026
7 weight loss companies to watch: innovators in GLP-1s and beyond
Biopharma Biotech Business Development

Pharma

온디맨드 웨비나 사이트런칭 온디맨드 웨비나 사이트런칭
Blog March 15, 2022
온디맨드 웨비나 사이트런칭
Navigating the choppy waters of 2027 health exchange enrollment Navigating the choppy waters of 2027 health exchange enrollment
Blog October 30, 2026
Navigating the choppy waters of 2027 health exchange enrollment
Most Favored Nation drug pricing: How it works Most Favored Nation drug pricing: How it works
Blog October 29, 2026
Most Favored Nation drug pricing: How it works
Multi-product portfolios: addressing complexity through smarter value communication Multi-product portfolios: addressing complexity through smarter value communication
Blog October 9, 2026
Multi-product portfolios: addressing complexity through smarter value communication
From promise to payment: pricing and reimbursement for combination oncology regimens From promise to payment: pricing and reimbursement for combination oncology regimens
Blog October 9, 2026
From promise to payment: pricing and reimbursement for combination oncology regimens
Faulty pharmaceutical forecasting can skew launch planning and sour investors Faulty pharmaceutical forecasting can skew launch planning and sour investors
Blog September 25, 2026
Faulty pharmaceutical forecasting can skew launch planning and sour investors
Biopharma’s pricing pains: Trump’s MFN policy scrambles launch plans Biopharma’s pricing pains: Trump’s MFN policy scrambles launch plans
Blog September 22, 2026
Biopharma’s pricing pains: Trump’s MFN policy scrambles launch plans
How three clinical trial registries tracked a $718M obesity drug (and why one wasn't enough) How three clinical trial registries tracked a $718M obesity drug (and why one wasn't enough)
Blog August 25, 2026
How three clinical trial registries tracked a $718M obesity drug (and why one wasn't enough)
7 weight loss companies to watch: innovators in GLP-1s and beyond 7 weight loss companies to watch: innovators in GLP-1s and beyond
Blog August 5, 2026
7 weight loss companies to watch: innovators in GLP-1s and beyond
The promise – and limitations – of AI in JCA PICO planning for pharmas and medtechs The promise – and limitations – of AI in JCA PICO planning for pharmas and medtechs
Blog July 28, 2026
The promise – and limitations – of AI in JCA PICO planning for pharmas and medtechs
Tracking the mid-year momentum of the 2026 Drugs to Watch Tracking the mid-year momentum of the 2026 Drugs to Watch
Blog July 8, 2026
Tracking the mid-year momentum of the 2026 Drugs to Watch